With the Food and Drug Administration approval of 9 agents for different acute myeloid leukemia (AML) indications, the prognosis and management of AML is evolving rapidly. Herein, we review the important milestones in the history of AML research and therapy, discuss insights regarding prognostic assessment and prediction of treatment outcome, detail practical supportive care measures, and summarize the current treatment landscape and areas of evolving research.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clml.2021.05.016 | DOI Listing |
Publication Analysis
Top Keywords
acute myeloid
8
myeloid leukemia
8
leukemia historical
4
historical perspective
4
perspective progress
4
progress therapy
4
therapy decades
4
decades food
4
food drug
4
drug administration
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!